AstraZeneca to invest $50bn in US by 2030 amid Trump tariff threats
by Lauren Almeida from US news | The Guardian on (#6YT2G)
UK company to fund new drug manufacturing facility in Virginia and expand R&D facilities around US
AstraZeneca has announced it will invest $50bn (37bn) in the US by 2030, the latest in a string of pledges by pharmaceutical companies as the threat of Donald Trump's tariffs looms over the industry.
The British drugmaker, which is headquartered in Cambridge, said its investment would fund a new drug manufacturing facility in Virginia and expand its research and development and cell therapy manufacturing in Maryland, Massachusetts, California, Indiana and Texas.
Continue reading...